logo-loader
viewWeedMD Inc

WeedMD posts record revenue of C$12.2 million in first quarter as it sees benefit of Starseed deal

In the three months to March 31, the cannabis producer and distributor posted net revenue of C$12.2 million

WeedMD Inc -
"We have both the operational infrastructure and balance sheet to support our continued commercial growth and broader distribution channels," WeedMD said

WeedMD Inc (CVE:WMD) (OTCQX:WDDMF) posted record revenue in its first quarter as the company benefits from its combination with medical cannabis group Starseed Medicinal Inc and continues to see its brands gaining recognition.

In the three months to March 31, the cannabis producer and distributor posted net revenue of C$12.2 million, which was 327% higher than the C$2.9 million seen in 4Q, 2019 and 265% more than the C$3.3 million generated in 1Q last year.

READ: WeedMD says its cannabis products included in University Health Network national study

Gross profit before changes in fair value was C$1.4 million, leading to an 11% gross margin compared to a gross loss of 70% in the previous quarter, mainly down to the sale of dried cannabis and revenue generated during the full quarter post the Starseed acquisition in December last year, the firm said.

Starseed provides medical cannabis as a fully covered drug benefit for union members and gave WeedMD a built-in partnership with Canada’s largest construction union, the Laborers’ International Union of North America (LiUNA), with over 100,000 members.

"The first quarter began to show the benefits of our combination with Starseed, as exemplified in our sales revenue mix along with the $25 million strategic equity investment we received from the LiUNA Pension Fund of Central and Eastern Canada,” Lincoln Greenidge, the finance chief at WeedMD, explained in the group's results statement.

"We have both the operational infrastructure and balance sheet to support our continued commercial growth and broader distribution channels," he added.

The addition of Starseed gives WeedMD potential access to a substantial and direct consumer audience, which is expected to drive growth and margin expansion, the company added.

In the first quarter, WeedMD sold 5,084 kgs of dried cannabis, up 744% on the previous quarter, while as at end-March, the company held C$37.8 million in inventory and biological assets and its total assets stood at C$213.7 million.

The loss for the three months came in at C$9 million, up from a loss of C$7.2 million in the preceding quarter.

"With our unique medical platform and expanded market presence of our mass-craft adult-use products, we are well-positioned to advance our customer-centric strategy and capitalize on positive market trends in the Canadian cannabis market," concluded Angelo Tsebelis, the chief executive of WeedMD.

Shares slipped 10.6% in Toronto to C$0.42.

Contact the author at [email protected]

Quick facts: WeedMD Inc

Price: 0.36 CAD

TSX-V:WMD
Market: TSX-V
Market Cap: $75.69 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 2/12/19

2 min read